<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/164505</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T17:37:01.000Z</news:publication_date>
      <news:title>First round of Trump&apos;s 100% pharma tariffs won&apos;t start Friday as planned</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164214</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T16:03:00.000Z</news:publication_date>
      <news:title>FTC Sues Hims &amp; Hers for Alleged Illegal Sharing of Patient Data and Deceptive Billing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164081</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:58:35.000Z</news:publication_date>
      <news:title>Trump&apos;s CDC nominee Erica Schwartz clears key Senate committee vote</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164215</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:52:00.000Z</news:publication_date>
      <news:title>Johnson &amp; Johnson secures option to acquire in-vivo CAR-T developer Sail Biomedicines for up to $2.6 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164174</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:32:44.000Z</news:publication_date>
      <news:title>BMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164175</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:29:13.000Z</news:publication_date>
      <news:title>Regeneron defends M&amp;A stance as cash hoard reaches $18 billion amid trial setbacks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164082</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:24:12.000Z</news:publication_date>
      <news:title>UCB stock slides despite Bimzelx revenue beating forecasts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164083</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:18:33.000Z</news:publication_date>
      <news:title>Garijo&apos;s plan to revamp Sanofi: an R&amp;D cleanup, more M&amp;A and a China push</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164084</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:16:51.000Z</news:publication_date>
      <news:title>Pfizer&apos;s Phase 3 win for Litfulo; Braveheart, Attovia eye IPOs of $275M, $182M</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164085</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:10:46.000Z</news:publication_date>
      <news:title>AtaiBeckley attracted co-development and royalty offers before $2.8B Lilly deal</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163953</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T15:02:43.000Z</news:publication_date>
      <news:title>Takeda, Regeneron, Sanofi and Bristol Myers Squibb announce pipeline cuts in quarterly updates</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163954</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T14:22:50.000Z</news:publication_date>
      <news:title>Included Health to acquire Firefly Health, signaling push into alternative health plans</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163830</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T14:17:10.000Z</news:publication_date>
      <news:title>Senate health panel confirms Trump picks for CDC director and pandemic preparedness chief</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163786</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T14:16:49.000Z</news:publication_date>
      <news:title>Ipsen says €2 billion cash reserves give it firepower for more M&amp;A</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163909</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T13:55:00.000Z</news:publication_date>
      <news:title>Leo International Precision Health AG board member Leo Wang buys shares worth €55,933</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163908</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T13:55:00.000Z</news:publication_date>
      <news:title>Leo International Precision Health AG: Mr Leo Wang, Acquisition</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163721</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T13:45:55.000Z</news:publication_date>
      <news:title>Federal judge rejects 26 states&apos; bid to delay Medicaid work requirement rollout</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163657</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T13:30:04.000Z</news:publication_date>
      <news:title>Gerresheimer sells Centor and Primary Packaging Plastics units to Apax Partners for €1.5 billion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163658</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T13:25:38.000Z</news:publication_date>
      <news:title>Alnylam cuts Amvuttra sales guidance as demand shifts, hurting stock</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163722</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T13:22:30.000Z</news:publication_date>
      <news:title>STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163701</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T13:20:37.000Z</news:publication_date>
      <news:title>Daiichi’s pipeline falls behind rivals as cash flow nears peak: analysts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163573</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T13:08:40.000Z</news:publication_date>
      <news:title>FDA panel rejects Capricor&apos;s Duchenne drug, citing insufficient efficacy data</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163385</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T11:51:15.000Z</news:publication_date>
      <news:title>J&amp;J strikes up to $925M deal with Sail Biomedicines, secures option to buy for $2.58B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163277</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T11:49:48.000Z</news:publication_date>
      <news:title>Ebola cases approach key milestone as vaccine candidates draw near completion</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163257</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T11:44:28.000Z</news:publication_date>
      <news:title>Sanofi CEO pledges deeper review of late-stage pipeline before Phase 3 moves</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163258</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T11:20:47.000Z</news:publication_date>
      <news:title>Arvinas CEO outlines strategy to rebuild pipeline after lead asset departure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163233</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T11:12:42.000Z</news:publication_date>
      <news:title>Relation promises &apos;transformationally different success rates&apos; in expanded AI pact with GSK</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164125</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T10:39:00.000Z</news:publication_date>
      <news:title>BMS CEO Boerner doesn’t ‘feel any compulsion to chase deals’ despite lack of M&amp;A this year</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162981</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T10:00:00.000Z</news:publication_date>
      <news:title>FDA advisory panel reviews Replimune&apos;s experimental melanoma therapy RP1</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163761</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T09:43:00.000Z</news:publication_date>
      <news:title>Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162789</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T09:35:05.000Z</news:publication_date>
      <news:title>Sanofi books over €1 billion impairment after ending eczema drug and halting two immunology programs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163635</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T08:58:00.000Z</news:publication_date>
      <news:title>Attovia, Braveheart and Vogenx seek more than $500M across trio of IPOs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162727</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T08:30:00.000Z</news:publication_date>
      <news:title>Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162726</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T08:30:00.000Z</news:publication_date>
      <news:title>Experts warn U.S. pharma reliance on China poses national security threat</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162725</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T08:30:00.000Z</news:publication_date>
      <news:title>Medicaid work rules spark confusion over medically frail exemption, risking coverage for chronically ill</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163504</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T08:21:00.000Z</news:publication_date>
      <news:title>Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163634</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T07:28:00.000Z</news:publication_date>
      <news:title>Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to one</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162281</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T07:00:00.000Z</news:publication_date>
      <news:title>Four biotech firms secure Series B funding and open new hiring opportunities</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162282</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T07:00:00.000Z</news:publication_date>
      <news:title>Biopharma layoffs in 2026 often marred by impersonal and poorly timed communications</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163632</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T06:36:00.000Z</news:publication_date>
      <news:title>GSK pens $110M biological datasets pact with AI biotech Relation</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162765</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T05:01:00.000Z</news:publication_date>
      <news:title>Sanofi’s new CEO vows deeper review of late-stage pipeline after series of trial failures</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/161941</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T04:32:19.000Z</news:publication_date>
      <news:title>Johnson &amp; Johnson prepares $2.58 billion option to acquire Sail Biomedicines, expanding in-vivo CAR-T portfolio</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/161798</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T04:17:00.000Z</news:publication_date>
      <news:title>Biogen’s early Phase 2 data supports tau-targeting Alzheimer’s approach</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/161709</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T04:05:00.000Z</news:publication_date>
      <news:title>Red Bull-funded studies downplay risks of mixing energy drinks with alcohol, shaping policy despite independent warnings</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163741</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T04:00:00.000Z</news:publication_date>
      <news:title>Convenience Kit Correction: Argon Medical Issues Correction for Convenience Kits Containing Spectra Medical Device Lidocaine Ampules</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/163633</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T03:55:00.000Z</news:publication_date>
      <news:title>Boston Scientific cuts guidance again after unveiling restructuring plan</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/162764</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-30T03:19:00.000Z</news:publication_date>
      <news:title>J&amp;J invests $785M in Sail Biomedicines, secures option to buy for $2.58B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/164410</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T22:43:56.000Z</news:publication_date>
      <news:title>FDA advisers vote against approval of Capricor’s DMD therapy in chaotic adcomm meeting</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/160693</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T22:43:56.000Z</news:publication_date>
      <news:title>FDA advisory panel votes 9-3 against Capricor&apos;s Duchenne therapy deramiocel</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/160280</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T21:36:13.000Z</news:publication_date>
      <news:title>NSF launches $47 million pilot to create joint university-industry Ph.D. programs for life scientists</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/160477</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T21:31:00.000Z</news:publication_date>
      <news:title>FDA advisory panel rejects Capricor&apos;s Duchenne heart-cell therapy deramiocel</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/160201</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T21:22:00.000Z</news:publication_date>
      <news:title>MapLight Therapeutics&apos; mid-stage schizophrenia trial shows modest improvement but shares plunge two-thirds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/160181</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T21:00:00.000Z</news:publication_date>
      <news:title>Latigo&apos;s mid-stage trial shows non-opioid pill LTG-001 cuts post-surgery pain, outperforms placebo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159841</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T19:48:29.000Z</news:publication_date>
      <news:title>FTC sues Hims &amp; Hers over alleged health data sharing and deceptive billing practices</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159704</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T19:14:46.000Z</news:publication_date>
      <news:title>US releases $600M pledged to global vaccine alliance Gavi after year‑long delay</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159649</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T18:45:33.000Z</news:publication_date>
      <news:title>FTC sues Hims &amp; Hers for misleading consumers and privacy violations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159629</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T18:43:38.000Z</news:publication_date>
      <news:title>Caldera and Vidya secure $478M via reverse mergers to go public</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159605</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T18:11:22.000Z</news:publication_date>
      <news:title>FDA and Capricor clash over Duchenne cell therapy efficacy at advisory committee</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/160516</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T17:51:00.000Z</news:publication_date>
      <news:title>FDA advisory panel rejects Capricor’s Duchenne cardiomyopathy cell therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159309</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T17:27:21.000Z</news:publication_date>
      <news:title>Teva says it has time to prepare for upcoming US tariffs on imported generic drugs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159181</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T17:02:49.000Z</news:publication_date>
      <news:title>NYU&apos;s Neil Vasan steps down as acting chair of FDA&apos;s oncology drug advisory committee</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159441</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T16:10:31.000Z</news:publication_date>
      <news:title>FDA approves first freeze-dried plasma product for U.S. use</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158989</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T16:07:00.000Z</news:publication_date>
      <news:title>Caldera Therapeutics merges with Synlogic, secures $278M to advance inflammation drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159137</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T16:00:00.000Z</news:publication_date>
      <news:title>Vaisala senior executive Vesa Pylvänäinen sells 117 shares at €57 each on Nasdaq Helsinki</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159136</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T16:00:00.000Z</news:publication_date>
      <news:title>Vesa Pylvänäinen sells 117 Vaisala shares at €57 each</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158990</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T15:40:00.000Z</news:publication_date>
      <news:title>Vertex and AbCellera team up to develop next-generation T-cell engagers for autoimmune diseases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158885</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T15:17:35.000Z</news:publication_date>
      <news:title>Atea&apos;s hepatitis C combo therapy shows non-inferior results to Gilead&apos;s Epclusa</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158821</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T15:13:00.000Z</news:publication_date>
      <news:title>Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158843</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T15:00:00.000Z</news:publication_date>
      <news:title>Nokia reports senior executive Kristen Pressner purchases 66,324 shares at €7.84 each</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158841</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T15:00:00.000Z</news:publication_date>
      <news:title>Nokia senior manager Mikko Hautala buys 7,103 shares at €7.84 each</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158842</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T15:00:00.000Z</news:publication_date>
      <news:title>Nokia senior manager Kristen Pressner purchases 66,324 shares at €7.84 each</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158840</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T15:00:00.000Z</news:publication_date>
      <news:title>Nokia senior manager Mikko Hautala buys 7,103 shares at €7.84 each</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158992</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T15:00:00.000Z</news:publication_date>
      <news:title>FDA reviewers doubt Replimune’s melanoma therapy as shares tumble 40%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158801</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:58:30.000Z</news:publication_date>
      <news:title>Trump administration ends Medicare drug plan subsidies, raising cost concerns ahead of midterms</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158673</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:54:44.000Z</news:publication_date>
      <news:title>Biogen shifts M&amp;A strategy as Apellis acquisition pushes revenue above analyst expectations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158649</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T14:46:38.000Z</news:publication_date>
      <news:title>Two biotech firms announce reverse mergers to list experimental bispecific antibody and BTK inhibitor on Nasdaq</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159679</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T13:59:00.000Z</news:publication_date>
      <news:title>Merck briefly lists, then removes, phase 2 trial of PD-1xVEGF bispecific with TROP2 ADC</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158505</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T13:37:24.000Z</news:publication_date>
      <news:title>Kyverna partners with ElevateBio to supply its autologous CAR-T therapy for autoimmune launches</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158525</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T13:36:01.000Z</news:publication_date>
      <news:title>Fugitive Discovered Working Under Alias in Biotech Industry Amid Legal Battles Involving AstraZeneca and Lilly</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158526</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T13:29:39.000Z</news:publication_date>
      <news:title>Benchmarking Clinical LLMs Proves Complex After Recent Nature Medicine Study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158506</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T13:26:04.000Z</news:publication_date>
      <news:title>Oncology experience not always required for pharma jobs, recruiters say</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158507</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T13:21:03.000Z</news:publication_date>
      <news:title>Biopharma job postings in New York rise 34% over past year, seven companies now hiring</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158357</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T12:56:26.000Z</news:publication_date>
      <news:title>Incyte drops early-stage JAK2 inhibitor to prioritize next-generation pipeline</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158377</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T12:55:57.000Z</news:publication_date>
      <news:title>Fauci invokes Fifth Amendment, declines to answer Covid-19 origins questions at Senate hearing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158358</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T12:38:10.000Z</news:publication_date>
      <news:title>Novo Nordisk faces shareholder fraud lawsuit over undisclosed dosing changes in CagriSema Phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158057</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T12:00:44.000Z</news:publication_date>
      <news:title>AI startup Doctronic acquires text-message pediatric care provider Summer Health</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/159580</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T11:57:00.000Z</news:publication_date>
      <news:title>Nanoparticle-loaded chemotherapy crosses blood-brain barrier in mice after glioblastoma surgery, study shows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158101</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T11:50:20.000Z</news:publication_date>
      <news:title>Morning Rounds flags overlooked pedestrian and cyclist deaths, upcoming Fauci Senate hearing, and research visa limits</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/134233</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T11:49:00.000Z</news:publication_date>
      <news:title>CLINUVEL to cut up to 20% of staff and move headquarters to New York</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/123087</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T11:33:00.000Z</news:publication_date>
      <news:title>BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158083</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T11:19:00.000Z</news:publication_date>
      <news:title>FDA briefing hints tough road for Capricor and Replimune ahead of advisory committee meetings</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/157929</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T11:00:37.000Z</news:publication_date>
      <news:title>Former Recursion CEO Chris Gibson joins Dimension Capital as operating partner</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158860</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T10:52:00.000Z</news:publication_date>
      <news:title>Biogen CEO says company will pause new acquisitions and focus on developing existing pipeline</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158624</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T10:30:00.000Z</news:publication_date>
      <news:title>Novo Nordisk loses bid to dismiss lawsuit over CagriSema trial readout</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158625</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T10:12:00.000Z</news:publication_date>
      <news:title>Processa Pharma acquires Vidya Therapeutics, gaining oral BTK inhibitor VT-7208</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/157633</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T10:00:26.000Z</news:publication_date>
      <news:title>Leqembi posts $184M Q2 sales, best quarter since launch, Biogen lifts guidance</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/157697</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T10:00:00.000Z</news:publication_date>
      <news:title>STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158626</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T08:56:00.000Z</news:publication_date>
      <news:title>Caldera Therapeutics completes reverse merger with Synlogic, secures $278 million financing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/157551</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T08:30:00.000Z</news:publication_date>
      <news:title>Former VA Secretary argues the Veterans Health Administration can boost US biotech competitiveness against China</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/157552</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T08:30:00.000Z</news:publication_date>
      <news:title>Prolonged hospital stays leave children isolated, urging change</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/157550</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T08:30:00.000Z</news:publication_date>
      <news:title>Most-wanted fugitive Ronald Fischer operated under alias in biotech industry for two decades</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/157549</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T08:30:00.000Z</news:publication_date>
      <news:title>Study finds clinical chatbots lag behind general AI models in accuracy, sparking debate among doctors</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/158171</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T08:09:00.000Z</news:publication_date>
      <news:title>Vertex pays $28 million upfront to AbCellera for autoimmune T-cell engager collaboration</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/156789</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-29T04:57:00.000Z</news:publication_date>
      <news:title>Biotech earnings season kicks off as Agios reports Phase 2 setback for sickle-cell drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/155785</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T23:34:07.000Z</news:publication_date>
      <news:title>ADA faces member backlash and calls for CEO and CSO resignations after expert expulsions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/155358</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T21:15:04.000Z</news:publication_date>
      <news:title>Webinar: Building the Intelligence Engine for Drug Discovery R&amp;D Teams</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/155054</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T19:29:57.000Z</news:publication_date>
      <news:title>Six key issues we’re watching at Fauci’s hearing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/155010</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T19:08:10.000Z</news:publication_date>
      <news:title>FDA reminds investors about the risks of advisory panels</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/154794</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T18:33:11.000Z</news:publication_date>
      <news:title>J&amp;J proposes $5.5B talc settlement</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/154795</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-07-28T18:08:40.000Z</news:publication_date>
      <news:title>FDA offers updated guidance for generics of weight loss blockbusters</news:title>
    </news:news>
  </url>
</urlset>
